about
The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowthInhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelinationSex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's DiseaseReductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist.Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease.BLOC-1 deficiency causes alterations in amino acid profile and in phospholipid and adenosine metabolism in the postnatal mouse hippocampus.Early effects of lipopolysaccharide-induced inflammation on foetal brain development in rat.Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease.STAT3-mediated astrogliosis protects myelin development in neonatal brain injury.Misaligned feeding impairs memories.Decreased reelin expression and organophosphate pesticide exposure alters mouse behaviour and brain morphologyAntagonism of convulsions but failure to enhance GABA(A) receptor function by felbamate in mice tolerant to diazepam.Cellular and molecular mechanisms of neurodevelopmental disorders.Circadian rhythm disruption in a mouse model of Rett syndrome circadian disruption in RTT.Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.NMDA receptor function is enhanced in the hippocampus of aged rats.Chronic administration of an anticonvulsant dose of imidazenil fails to induce tolerance of GABAA receptor function in mice.Antagonism by abecarnil of enhanced acetylcholine release in the rat brain during anticipation but not consumption of food.Gene expression is differentially regulated by neurotransmitters in embryonic neuronal cortical culture.Biochemical evaluations of the effects of loreclezole and propofol on the GABAA receptor in rat brain.Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington’s diseaseCircadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington’s DiseaseBlue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease.Sleep/Wake Disruption in a Mouse Model of BLOC-1 DeficiencyFailure of Chronic Treatment with Abecarnil to Induce Contingent and Noncontingent Tolerance in Pentylenetetrazol-Kindled RatsLong-term treatment with abecarnil fails to induce tolerance in miceGlial heterogeneity in expression of the inwardly rectifying K(+) channel, Kir4.1, in adult rat CNSCircadian dysfunction in the Q175 model of Huntington's disease: Network analysisPotential Circadian Rhythms in Oligodendrocytes? Working Together Through TimeQuantitative assessments reveal improved neuroscience engagement and learning through outreachSex-dimorphic effects of biogenesis of lysosome-related organelles complex-1 deficiency on mouse perinatal brain development
P50
Q24338919-4FB8D257-2F94-40E2-A89A-48F193E6CCA7Q24627168-43CE0A27-2253-4C86-A887-89D9AB6C7CE4Q28386809-4C71DBC5-91F8-4D3C-A74C-587BD01C7551Q30382547-B39FF34A-4F30-4883-A615-34A7BE9BFC2FQ30474256-F3950937-CF40-4E2D-8106-5C42D58D100BQ33800209-602EE859-4B26-473F-97BB-6917638FC5CEQ33899339-C2D67851-6CE8-4437-A1A7-E585680C8A5CQ35556890-47556FBB-9CEF-41B3-9CA8-595F21B8E8A8Q35903061-B0186CCE-BF3E-438F-9AE5-23E95BFA75B5Q36445816-8A57FA1E-33BE-41A8-9C86-FED72560178BQ36510606-BE24112B-D142-4B11-BFDB-E319957C5BE3Q36617356-F7870594-F94D-4F31-A3C9-143BC1E292A9Q42549228-E19BEE8B-7B9E-4F09-8D9C-82236C4C3E31Q43172226-CC2A611A-AC66-49C8-A6CF-E7F3E0156BB5Q46514245-DE9FC9FB-3915-42A3-B210-1902575BA7FCQ47983511-4F6C7218-511C-4B1A-9581-6DD83B5DC507Q48151654-9CB0A8A9-C88D-4482-9B13-50A591727AE9Q48155291-930F1F1A-0E87-4F77-B890-C9AB48A24324Q48505920-7771DD7D-87F7-4516-A991-15BA215541E3Q48570104-E15A6B0A-845A-4658-A771-A813A0D50264Q51568846-E59D8398-B2C3-405E-A1BB-E2E2FDB43439Q57446278-5F0BBCF2-4040-4207-A120-6D2088228AAAQ57446280-5BECF0C7-840A-4198-A528-77120DBC672EQ57446281-A6778360-168A-4AEB-ABC6-7C08AC9B9E39Q59327120-F99CC379-AB3C-484C-B7BE-8A2209282046Q61822121-D912E2DA-8AB6-46AE-B548-04B20B633E4FQ62985275-648561A8-E44F-4CBF-A03A-3E14D8C78A49Q73748147-EFE5A76A-67E5-4219-B5C3-F71D6E38AE90Q92270925-AB60DB55-301A-428B-9250-BE381A22731BQ92588211-2137A3C8-5E32-4D57-B723-7E5FE2133791Q93092043-57394397-7D61-4805-8702-E52AECE47EE3Q95277629-DBB519F5-53EB-4F72-871F-C1B5A7B28563
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristina A. Ghiani
@ast
Cristina A. Ghiani
@en
Cristina A. Ghiani
@es
Cristina A. Ghiani
@nl
Cristina A. Ghiani
@sl
type
label
Cristina A. Ghiani
@ast
Cristina A. Ghiani
@en
Cristina A. Ghiani
@es
Cristina A. Ghiani
@nl
Cristina A. Ghiani
@sl
prefLabel
Cristina A. Ghiani
@ast
Cristina A. Ghiani
@en
Cristina A. Ghiani
@es
Cristina A. Ghiani
@nl
Cristina A. Ghiani
@sl
P106
P1153
6603343351
P21
P2798
P31
P496
0000-0002-9867-6185